Reactivation of immanent herpes group virus.
Sawada
Shigemasa
S
Takei
Masami
M
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D003093:Colitis, Ulcerative / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D015654:Herpesvirus 6, Human / Q000276:immunology* / Q000502:physiology; D006801:Humans; D011379:Prognosis; D018570:Risk Assessment; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use; D014775:Virus Activation / Q000187:drug effects*; D017735:Virus Latency / Q000187:drug effects / Q000502:physiology
D000914:Antibodies, Viral; D012460:Sulfasalazine